Key Sessions
Frederik Buysse
Keynote: Building a CAR-T Manufacturing Facility from a Greenfield to Operation
Legend Biotech
Hiroyuki Usuda
Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing
Astellas Pharma Europe Ltd
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Topics
Monday 1st December – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Clear
Topics
Showing 1 of 1 Streams
Cell Therapy
11:10 - 11:15
Chairperson's Opening Remarks
- Stijn Heessen - Co-founder, COO, Alder Therapeutics AB
11:15 - 11:45
Case Study: Enhancing Implementation of GMP Manufacturing Processes
- Jan Spanholtz - CSO, Glycostem Therapeutics
11:45 - 12:15
Scalable TCR-T Discovery and Manufacturing
- Anette Brass - Head of Process Development, Anocca
12:15 - 12:45
From Bench to Bedside: Overcoming Challenges in Arenavirus-Based Cancer Immunotherapy Manufacturing
- Dethardt Müeller - Chief Technology Officer - CMC, Abalos Therapeutics GmbH
Showing 1 of 1 Streams
Cell Therapy
14:00 - 14:30
Automated, Dynamic Expansion of Allogeneic NK Cells: A Modular Platform Technology from the Project “RNAuto”
- Andrea Gaißler - Research Associate, Fraunhofer Institute for Manufacturing Engineering and Automation IPA
14:30 - 15:00
Mesenchymal Stromal Cell Therapy for the Treatment of Type 1 Diabetes
- Lindsay Davies - Chief Scientific Officer, NextCell Pharma
15:00 - 15:30
From Clone to Cure: Building Robust Starting Material for iPSC-Based Therapeutics
- Olivia Candini - Head of Process Development, Cell & Gene Therapy, Evotec Modena
Showing 1 of 1 Streams
Cell Therapy
16:10 - 16:40
Advances in Manufacturing of iPSC Derived NK Cells for Immunotherapy
- Marina Tarunina - Research Director, Plasticell Ltd
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Topics
